Here are some of its competitors that are already FDA approved for weight management: Liraglutide (Saxenda) : This injectable medication is a once-daily GLP-1 receptor agonist approved for chronic weight management in adults with a body mass index (BMI) of 30 or greater (obesity) or 27 or greater (overweight) with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
Use our: GLP-1 (Tirzepatide / Semaglutide) Dose to Units Calculator You may also want to read: These resources explain how dosing progresses and what patients typically experience during treatment
More recently, in March 2024, Wegovy was This approval followed promising results from novo Nordisks SELECT trial, which followed 17,604 adults with obesity or overweight and cardiovascular disease but no history of diabetes
Acetyl L-Carnitine, characterized by the addition of an acetyl group, is a molecular variation of L-Carnitine that is believed to possess superior bioavailability and potential cognitive benefits due to its ability to traverse the blood-brain barrier
